Identification and performance evaluation of housekeeping genes for microRNA expression normalization by reverse transcription‑quantitative PCR using liquid‑based cervical cytology samples
- Authors:
- Rhafaela Lima Causin
- Danielle Pessôa‑Pereira
- Karen Cristina Borba Souza
- Adriane Feijó Evangelista
- Rui Manuel Vieira Reis
- José Humberto Tavares Guerreiro Fregnani
- Márcia Maria Chiquitelli Marques
-
Affiliations: Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo 14784‑400, Brazil, AC Camargo Cancer Center, São Paulo 01509‑010, Brazil - Published online on: September 6, 2019 https://doi.org/10.3892/ol.2019.10824
- Pages: 4753-4761
-
Copyright: © Causin et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
 |
 |
|
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Parkin DM and Bray F: The burden of HPV-related cancers. Vaccine. 24 (Suppl 3):S11–S25. 2006. View Article : Google Scholar | |
|
Iorio MV and Croce CM: Causes and consequences of microRNA dysregulation. Cancer J. 18:215–222. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
He Y, Lin J, Ding Y, Liu G, Luo Y, Huang M, Xu C, Kim TK, Etheridge A, Lin M, et al: A systematic study on dysregulated microRNAs in cervical cancer development. Int J Cancer. 138:1312–1327. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
He L and Hannon GJ: MicroRNAs: Small RNAs with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Pardini B, De Maria D, Francavilla A, Di Gaetano C, Ronco G and Naccarati A: MicroRNAs as markers of progression in cervical cancer: A systematic review. BMC Cancer. 18:6962018. View Article : Google Scholar : PubMed/NCBI | |
|
Di Meo A, Bartlett J, Cheng Y, Pasic MD and Yousef GM: Liquid biopsy: A step forward towards precision medicine in urologic malignancies. Mol Cancer. 16:802017. View Article : Google Scholar : PubMed/NCBI | |
|
Finotti A, Allegretti M, Gasparello J, Giacomini P, Spandidos DA, Spoto G and Gambari R: Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review). Int J Oncol. 53:1395–1434. 2018.PubMed/NCBI | |
|
Muinelo-Romay L, Casas-Arozamena C and Abal M: Liquid biopsy in endometrial cancer: New opportunities for personalized oncology. Int J Mol Sci. 19:E23112018. View Article : Google Scholar : PubMed/NCBI | |
|
Yao T, Rao Q, Liu L, Zheng C, Xie Q, Liang J and Lin Z: Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in cervical cancer. Virol J. 10:1752013. View Article : Google Scholar : PubMed/NCBI | |
|
Yang Y, Xie YJ, Xu Q, Chen JX, Shan NC and Zhang Y: Down-regulation of miR-1246 in cervical cancer tissues and its clinical significance. Gynecol Oncol. 138:683–688. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Yu Q, Liu SL, Wang H, Shi G, Yang P and Chen XL: miR-126 Suppresses the proliferation of cervical cancer cells and alters cell sensitivity to the chemotherapeutic drug bleomycin. Asian Pac J Cancer Prev. 14:6569–6572. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Wang L, Wang Q, Li HL and Han LY: Expression of MiR200a, miR93, metastasis-related gene RECK and MMP2/MMP9 in human cervical carcinoma-relationship with prognosis. Asian Pac J Cancer Prev. 14:2113–2118. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Yin ZL, Wang YL, Ge SF, Guo TT, Wang L, Zheng XM and Liu J: Reduced expression of miR-503 is associated with poor prognosis in cervical cancer. Eur Rev Med Pharmacol Sci. 19:4081–4085. 2015.PubMed/NCBI | |
|
Wang LQ, Zhang Y, Yan H, Liu KJ and Zhang S: MicroRNA-373 functions as an oncogene and targets YOD1 gene in cervical cancer. Biochem Biophys Res Commun. 459:515–520. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Song X, Shi B, Huang K and Zhang W: miR-133a inhibits cervical cancer growth by targeting EGFR. Oncol Rep. 34:1573–1580. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Li QQ, Zhang L, Wan HY, Liu M, Li X and Tang H: CREB1-driven expression of miR-320a promotes mitophagy by down-regulating VDAC1 expression during serum starvation in cervical cancer cells. Oncotarget. 6:34924–34940. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Wei Q, Li YX, Liu M, Li X and Tang H: MiR-17-5p targets TP53INP1 and regulates cell proliferation and apoptosis of cervical cancer cells. IUBMB Life. 64:697–704. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Chen J, Yao D, Li Y, Chen H, He C, Ding N, Lu Y, Ou T, Zhao S, Li L and Long F: Serum microRNA expression levels can predict lymph node metastasis in patients with early-stage cervical squamous cell carcinoma. Int J Mol Med. 32:557–567. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Yue C, Wang M, Ding B, Wang W, Fu S, Zhou D, Zhang Z and Han S: Polymorphism of the pre-miR-146a is associated with risk of cervical cancer in a Chinese population. Gynecol Oncol. 122:33–37. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou Q, Han LR, Zhou YX and Li Y: MiR-195 suppresses cervical cancer migration and invasion through targeting Smad3. Int J Gynecol Cancer. 26:817–824. 2016. View Article : Google Scholar | |
|
Chen XF and Liu Y: MicroRNA-744 inhibited cervical cancer growth and progression through apoptosis induction by regulating Bcl-2. Biomed Pharmacother. 81:379–387. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Sun Y, Yang X, Liu M and Tang H: B4GALT3 up-regulation by miR-27a contributes to the oncogenic activity in human cervical cancer cells. Cancer Lett. 375:284–292. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang J, Wang F, Xu J, Wang X, Ye F and Xie X: Micro ribonucleic acid-93 promotes oncogenesis of cervical cancer by targeting RAB11 family interacting protein 1. J Obstet Gynaecol Res. 42:1168–1179. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Xiao S, Liao S, Zhou Y, Jiang B, Li Y and Xue M: High expression of octamer transcription factor 1 in cervical cancer. Oncol Lett. 7:1889–1894. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Yi Y, Li H, Lv Q, Wu K and Zhang W, Zhang J, Zhu D, Liu Q and Zhang W: miR-202 inhibits the progression of human cervical cancer through inhibition of cyclin D1. Oncotarget. 7:72067–72075. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Cheng YX, Zhang QF, Hong L, Pan F, Huang JL, Li BS and Hu M: MicroRNA-200b suppresses cell invasion and metastasis by inhibiting the epithelial-mesenchymal transition in cervical carcinoma. Mol Med Rep. 13:3155–3160. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Sun L, Jiang R, Li J, Wang B, Ma C, Lv Y and Mu N: MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer. Ann Clin Biochem. 54:127–133. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Yu Y, Zhang Y and Zhang S: MicroRNA-92 regulates cervical tumorigenesis and its expression is upregulated by human papillomavirus-16 E6 in cervical cancer cells. Oncol Lett. 6:468–474. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Yang Y, Liu H, Wang X and Chen L: Up-regulation of microRNA-664 inhibits cell growth and increases cisplatin sensitivity in cervical cancer. Int J Clin Exp Med. 8:18123–18129. 2015.PubMed/NCBI | |
|
Qin X, Wan Y, Wang S and Xue M: MicroRNA-125a-5p modulates human cervical carcinoma proliferation and migration by targeting ABL2. Drug Des Devel Ther. 10:71–79. 2015.PubMed/NCBI | |
|
Sun P, Shen Y, Gong JM, Zhou LL, Sheng JH and Duan FJ: A new MicroRNA expression signature for cervical cancer. Int J Gynecol Cancer. 27:339–343. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Chandrasekaran KS, Sathyanarayanan A and Karunagaran D: MicroRNA-214 suppresses growth, migration and invasion through a novel target, high mobility group AT-hook 1, in human cervical and colorectal cancer cells. Br J Cancer. 115:741–751. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Lin W, Feng M, Chen G, Zhou Z, Li J and Ye Y: Characterization of the microRNA profile in early-stage cervical squamous cell carcinoma by next-generation sequencing. Oncol Rep. 37:1477–1486. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Azizmohammadi S, Safari A, Azizmohammadi S, Kaghazian M, Sadrkhanlo M, Yahaghi E, Farshgar R and Seifoleslami M: Molecular identification of miR-145 and miR-9 expression level as prognostic biomarkers for early-stage cervical cancer detection. QJM. 110:11–15. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Jin X, Chen X, Hu Y, Ying F, Zou R, Lin F, Shi Z, Zhu X, Yan X, Li S and Zhu H: LncRNA-TCONS_00026907 is involved in the progression and prognosis of cervical cancer through inhibiting miR-143-5p. Cancer Med. 6:1409–1423. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Liu J and Ni S: Association between genetic polymorphisms in the promoters of let-7 and risk of cervical squamous cell carcinoma. Gene. 642:256–260. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou Y, Hao Y, Li Y, Li R, Wu R, Wang S and Fang Z: Amplification and up-regulation of MIR30D was associated with disease progression of cervical squamous cell carcinomas. BMC Cancer. 17:2302017. View Article : Google Scholar : PubMed/NCBI | |
|
Song R, Cong L, Ni G and Chen M, Sun H, Sun Y and Chen M: MicroRNA-195 inhibits the behavior of cervical cancer tumors by directly targeting HDGF. Oncol Lett. 14:767–775. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao J, Li B, Shu C, Ma Y and Gong Y: Downregulation of miR-30a is associated with proliferation and invasion via targeting MEF2D in cervical cancer. Oncol Lett. 14:7437–7442. 2017.PubMed/NCBI | |
|
He S, Liao B, Deng Y, Su C, Tuo J, Liu J, Yao S and Xu L: MiR-216b inhibits cell proliferation by targeting FOXM1 in cervical cancer cells and is associated with better prognosis. BMC Cancer. 17:6732017. View Article : Google Scholar : PubMed/NCBI | |
|
Li S, Yang F, Wang M, Cao W and Yang Z: miR-378 functions as an onco-miRNA by targeting the ST7L/Wnt/β-catenin pathway in cervical cancer. Int J Mol Med. 40:1047–1056. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Hu Y, Xie H, Liu Y, Liu W, Liu M and Tang H: miR-484 suppresses proliferation and epithelial-mesenchymal transition by targeting ZEB1 and SMAD2 in cervical cancer cells. Cancer Cell Int. 17:362017. View Article : Google Scholar : PubMed/NCBI | |
|
Luo S, Li N, Yu S, Chen L, Liu C and Rong J: MicroRNA-92a promotes cell viability and invasion in cervical cancer via directly targeting Dickkopf-related protein 3. Exp Ther Med. 14:1227–1234. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Z, Wang J, Wang X, Song W, Shi Y and Zhang L: MicroRNA-21 promotes proliferation, migration, and invasion of cervical cancer through targeting TIMP3. Arch Gynecol Obstet. 297:433–442. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Li M, Li BY, Xia H and Jiang LL: Expression of microRNA-142-3p in cervical cancer and its correlation with prognosis. Eur Rev Med Pharmacol Sci. 21:2346–2350. 2017.PubMed/NCBI | |
|
Zhao Y, Liu X and Lu YX: MicroRNA-143 regulates the proliferation and apoptosis of cervical cancer cells by targeting HIF-1α. Eur Rev Med Pharmacol Sci. 21:5580–5586. 2017.PubMed/NCBI | |
|
Tao L, Zhang CY, Guo L, Li X, Han NN, Zhou Q and Liu ZL: MicroRNA-497 Accelerates Apoptosis While Inhibiting Proliferation, Migration, and Invasion through negative regulation of the MAPK/ERK signaling pathway via RAF-1. J Cell Physiol. 233:6578–6588. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Gocze K, Gombos K, Kovacs K, Juhasz K, Gocze P and Kiss I: MicroRNA expressions in HPV-induced cervical dysplasia and cancer. Anticancer Res. 35:523–530. 2015.PubMed/NCBI | |
|
Zhang J, Zheng F, Yu G, Yin Y and Lu Q: miR-196a targets netrin 4 and regulates cell proliferation and migration of cervical cancer cells. Biochem Biophys Res Commun. 440:582–588. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Chen Y, Ma C, Zhang W, Chen Z and Ma L: Down regulation of miR-143 is related with tumor size, lymph node metastasis and HPV16 infection in cervical squamous cancer. Diagn Pathol. 9:882014. View Article : Google Scholar : PubMed/NCBI | |
|
Wang C and Jiang T: MicroRNA-335 represents an independent prognostic marker in cervical cancer. Tumour Biol. 36:5825–5830. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Zeng K, Zheng W, Mo X, Liu F, Li M, Liu Z, Zhang W and Hu X: Dysregulated microRNAs involved in the progression of cervical neoplasm. Arch Gynecol Obstet. 292:905–913. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Ma L, Hong Y, Lu C, Chen Y and Ma C: The occurrence of cervical cancer in Uygur women in Xinjiang Uygur Autonomous Region is correlated to microRNA-146a and ethnic factor. Int J Clin Exp Pathol. 8:9368–9375. 2015.PubMed/NCBI | |
|
Zheng W, Liu Z, Zhang W and Hu X: miR-31 functions as an oncogene in cervical cancer. Arch Gynecol Obstet. 292:1083–1089. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Qian K, Pietilä T, Rönty M, Michon F, Frilander MJ, Ritari J, Tarkkanen J, Paulín L, Auvinen P and Auvinen E: Identification and Validation of Human Papillomavirus Encoded microRNAs. PLoS One. 8:e702022013. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang J, Jia J, Zhao L, Li X, Xie Q, Chen X, Wang J and Lu F: Down-regulation of microRNA-9 leads to activation of IL-6/Jak/STAT3 pathway through directly targeting IL-6 in HeLa cell. Mol Carcinog. 55:732–742. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao S, Yao D, Chen J and Ding N: Circulating miRNA-20a and miRNA-203 for screening lymph node metastasis in early stage cervical cancer. Genet Test Mol Biomark. 17:631–636. 2013. View Article : Google Scholar | |
|
Jia W, Wu Y, Zhang Q, Gao GE, Zhang C and Xiang Y: Expression profile of circulating microRNAs as a promising fingerprint for cervical cancer diagnosis and monitoring. Mol Clin Oncol. 3:851–858. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Jiang W, Pan JJ, Deng YH, Liang MR and Yao LH: Down-regulated serum microRNA-101 is associated with aggressive progression and poor prognosis of cervical cancer. J Gynecol Oncol. 28:e752017. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou LL, Shen Y, Gong JM, Sun P and Sheng JH: MicroRNA-466 with tumor markers for cervical cancer screening. Oncotarget. 8:70821–70827. 2017.PubMed/NCBI | |
|
Yu J, Wang Y, Dong R, Huang X, Ding S and Qiu H: Circulating microRNA-218 was reduced in cervical cancer and correlated with tumor invasion. J Cancer Res Clin Oncol. 138:671–674. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
You W, Wang Y and Zheng J: Plasma miR-127 and miR-218 Might Serve as Potential Biomarkers for Cervical Cancer. Reprod Sci. 22:1037–1041. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Luo M, Shen D, Wang W and Xian J: Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer. Int J Clin Exp Pathol. 8:5542–5548. 2015.PubMed/NCBI | |
|
Liu S, Pan X, Yang Q, Wen L, Jiang Y, Zhao Y and Li G: MicroRNA-18a enhances the radiosensitivity of cervical cancer cells by promoting radiation-induced apoptosis. Oncol Rep. 33:2853–2862. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Xie H, Lee L, Scicluna P, Kavak E, Larsson C, Sandberg R and Lui WO: Novel functions and targets of miR-944 in human cervical cancer cells. Int J Cancer. 136:E230–E241. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Shen S, Wang L, Jia Y, Hao Y, Zhang L and Wang H: Upregulation of microRNA-224 is associated with aggressive progression and poor prognosis in human cervical cancer. Diagn Pathol. 8:692013. View Article : Google Scholar : PubMed/NCBI | |
|
Huang L, Lin JX, Yu YH, Zhang MY, Wang HY and Zheng M: Downregulation of Six MicroRNAs Is Associated with Advanced Stage, Lymph Node Metastasis and Poor Prognosis in Small Cell Carcinoma of the Cervix. PLoS One. 7:e337622012. View Article : Google Scholar : PubMed/NCBI | |
|
Xing AY, Wang B, Shi DB, Zhang XF, Gao C, He XQ, Liu WJ and Gao P: Deregulated expression of miR-145 in manifold human cancer cells. Exp Mol Pathol. 95:91–97. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Lee H, Kim KR, Cho NH, Hong SR, Jeong H, Kwon SY, Park KH, An HJ, Kim TH, Kim I, et al: MicroRNA expression profiling and Notch1 and Notch2 expression in minimal deviation adenocarcinoma of uterine cervix. World J Surg Oncol. 12:3342014. View Article : Google Scholar : PubMed/NCBI | |
|
Ivanov MK, Titov SE, Glushkov SA, Dzyubenko VV, Malek AV, Arkhangelskaya PA, Samsonov RB, Mikhetko AA, Bakhidze EV, Berlev IV and Kolesnikov NN: Detection of high-grade neoplasia in air-dried cervical PAP smears by a microRNA-based classifier. Oncol Rep. 39:1099–1111. 2018.PubMed/NCBI | |
|
Yu X, Zhao W, Yang X, Wang Z and Hao M: miR-375 affects the proliferation, invasion, and apoptosis of HPV16-positive human cervical cancer cells by targeting IGF-1R. Int J Gynecol Cancer. 26:851–858. 2016. View Article : Google Scholar | |
|
Hao M, Zhao W, Zhang L, Wang H and Yang X: Low folate levels are associated with methylation-mediated transcriptional repression of miR-203 and miR-375 during cervical carcinogenesis. Oncol Lett. 11:3863–3869. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Nagamitsu Y, Nishi H, Sasaki T, Takaesu Y, Terauchi F and Isaka K: Profiling analysis of circulating microRNA expression in cervical cancer. Mol Clin Oncol. 5:189–194. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Kogo R, How C, Chaudary N, Bruce J, Shi W, Hill RP, Zahedi P, Yip KW and Liu FF: The microRNA-218~Survivin axis regulates migration, invasion, and lymph node metastasis in cervical cancer. Oncotarget. 6:1090–1100. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Lajer CB, Garnæs E, Friis-Hansen L, Norrild B, Therkildsen MH, Glud M, Rossing M, Lajer H, Svane D, Skotte L, et al: The role of miRNAs in human papilloma virus (HPV)-associated cancers: Bridging between HPV-related head and neck cancer and cervical cancer. Br J Cancer. 106:1526–1534. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Huang YW, Kuo CT, Chen JH, Goodfellow PJ, Huang TH, Rader JS and Uyar DS: Hypermethylation of miR-203 in endometrial carcinomas. Gynecol Oncol. 133:340–345. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Myklebust MP, Bruland O, Fluge Ø, Skarstein A, Balteskard L and Dahl O: MicroRNA-15b is induced with E2F-controlled genes in HPV-related cancer. Br J Cancer. 105:1719–1725. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Sharma Saha S, Roy Chowdhury R, Mondal NR, Chakravarty B, Chatterjee T, Roy S and Sengupta S: Identification of genetic variation in the lncRNA HOTAIR associated with HPV16-related cervical cancer pathogenesis. Cell Oncol (Dordr). 39:559–572. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Andersen CL, Jensen JL and Ørntoft TF: Normalization of real-time quantitative reverse transcription-PCR data: A model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res. 64:5245–5250. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Rossi ED, Bizzarro T, Martini M, Capodimonti S, Sarti D, Cenci T, Bilotta M, Fadda G and Larocca LM: The evaluation of miRNAs on thyroid FNAC: The promising role of miR-375 in follicular neoplasms. Endocrine. 54:723–732. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Kottaridi C, Spathis A, Margari N, Koureas N, Terzakis E, Chrelias C, Pappas A, Bilirakis E, Pouliakis A, Panayiotides IJ and Karakitsos P: Evaluation analysis of miRNAs overexpression in liquid-based cytology endometrial samples. J Cancer. 8:2699–2703. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Barodawala SM, Chadha K, Kavishwar V, Murthy A and Shetye S: Cervical cancer screening by molecular Pap-transformation of gynecologic cytology. Diagn Cytopathol. 47:374–381. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Bonde J, Ejegod DM, Cuschieri K, Dillner J, Heideman DAM, Quint W, Pavon Ribas MA, Padalko E, Christiansen IK, Xu L and Arbyn M: The Valgent4 protocol: Robust analytical and clinical validation of 11 HPV assays with genotyping on cervical samples collected in SurePath medium. J Clin Virol. 108:64–71. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Tota JE, Bentley J, Blake J, Coutlée F, Duggan MA, Ferenczy A, Franco EL, Fung-Kee-Fung M, Gotlieb W, Mayrand MH, et al: Approaches for triaging women who test positive for human papillomavirus in cervical cancer screening. Prev Med. 98:15–20. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Derveaux S, Vandesompele J and Hellemans J: How to do successful gene expression analysis using real-time PCR. Methods. 50:227–230. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Schmittgen TD and Livak KJ: Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Kiss T: Small nucleolar RNAs: An abundant group of noncoding RNAs with diverse cellular functions. Cell. 109:145–148. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Dieci G, Preti M and Montanini B: Eukaryotic snoRNAs: A paradigm for gene expression flexibility. Genomics. 94:83–88. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Zubillaga-Guerrero MI, Alarcón-Romero Ldel C, Illades-Aguiar B, Flores-Alfaro E, Bermúdez-Morales VH, Deas J and Peralta-Zaragoza O: MicroRNA miR-16-1 regulates CCNE1 (cyclin E1) gene expression in human cervical cancer cells. Int J Clin Exp Med. 8:15999–16006. 2015.PubMed/NCBI |
